Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation. (2024)
Attributed to:
Mathematical and Statistical Modelling to Optimise Paediatric Medicines Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.3078
PubMed Identifier: 37846495
Publication URI: http://europepmc.org/abstract/MED/37846495
Type: Journal Article/Review
Volume: 115
Parent Publication: Clinical pharmacology and therapeutics
Issue: 1
ISSN: 0009-9236